Quintiles Transitional Holdings Inc. (Q) Shares Bought by Candriam Luxembourg S.C.A.
Candriam Luxembourg S.C.A. raised its stake in Quintiles Transitional Holdings Inc. (NYSE:Q) by 2.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 22,950 shares of the medical research company’s stock after buying an additional 637 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Quintiles Transitional Holdings were worth $2,054,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in Q. BlackRock Inc. boosted its position in Quintiles Transitional Holdings by 4,217.1% in the first quarter. BlackRock Inc. now owns 7,098,723 shares of the medical research company’s stock worth $571,660,000 after buying an additional 6,934,290 shares during the last quarter. Gulf International Bank UK Ltd boosted its position in Quintiles Transitional Holdings by 1.1% in the first quarter. Gulf International Bank UK Ltd now owns 49,056 shares of the medical research company’s stock worth $3,950,000 after buying an additional 545 shares during the last quarter. Creative Planning boosted its position in Quintiles Transitional Holdings by 35.4% in the first quarter. Creative Planning now owns 4,482 shares of the medical research company’s stock worth $361,000 after buying an additional 1,172 shares during the last quarter. Todd Asset Management LLC boosted its position in Quintiles Transitional Holdings by 103.0% in the first quarter. Todd Asset Management LLC now owns 219,381 shares of the medical research company’s stock worth $17,667,000 after buying an additional 111,288 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in Quintiles Transitional Holdings by 15.7% in the first quarter. Russell Investments Group Ltd. now owns 50,658 shares of the medical research company’s stock worth $4,080,000 after buying an additional 6,865 shares during the last quarter. Institutional investors and hedge funds own 91.83% of the company’s stock.
Quintiles Transitional Holdings Inc. (Q) opened at 87.57 on Friday. The company’s 50-day moving average price is $90.07 and its 200-day moving average price is $83.42. Quintiles Transitional Holdings Inc. has a 52-week low of $70.10 and a 52-week high of $93.53. The company has a market cap of $18.96 billion, a price-to-earnings ratio of 253.83 and a beta of 0.64.
Quintiles Transitional Holdings (NYSE:Q) last posted its earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The company had revenue of $1.97 billion during the quarter, compared to analyst estimates of $1.96 billion. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. Quintiles Transitional Holdings’s revenue was up 68.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.93 earnings per share. Equities research analysts expect that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current fiscal year.
Quintiles Transitional Holdings announced that its Board of Directors has approved a stock repurchase plan on Wednesday, May 24th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the medical research company to buy up to 5.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s management believes its stock is undervalued.
TRADEMARK VIOLATION NOTICE: This story was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.watchlistnews.com/quintiles-transitional-holdings-inc-q-shares-bought-by-candriam-luxembourg-s-c-a/1472853.html.
A number of research analysts have recently commented on Q shares. Zacks Investment Research cut Quintiles Transitional Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, April 26th. Robert W. Baird upgraded Quintiles Transitional Holdings from an “underperform” rating to a “neutral” rating and raised their target price for the company from $76.00 to $93.00 in a research note on Friday, July 7th. Jefferies Group LLC raised their target price on Quintiles Transitional Holdings from $78.00 to $81.00 and gave the company a “hold” rating in a research note on Monday, May 15th. Evercore ISI restated an “in-line” rating and issued a $88.50 target price (up previously from $84.00) on shares of Quintiles Transitional Holdings in a research note on Thursday, May 4th. Finally, Credit Suisse Group restated an “outperform” rating and issued a $96.00 target price (up previously from $94.00) on shares of Quintiles Transitional Holdings in a research note on Tuesday, June 6th. Eleven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $89.94.
In other news, insider Ari Bousbib sold 92,160 shares of the stock in a transaction on Monday, August 7th. The stock was sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the completion of the sale, the insider now owns 1,082,919 shares in the company, valued at approximately $97,841,731.65. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Cpp Investment Board Private H sold 7,131,165 shares of the stock in a transaction on Wednesday, May 31st. The shares were sold at an average price of $84.01, for a total value of $599,089,171.65. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,850,560 shares of company stock valued at $744,110,641. 6.40% of the stock is owned by company insiders.
About Quintiles Transitional Holdings
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding Q? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quintiles Transitional Holdings Inc. (NYSE:Q).
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.